Chemed (CHE) Equity Average (2010 - 2026)

Chemed's Equity Average history runs 17 years deep, the most recent figure standing at $913.7 million for Q1 2026.

• In Q1 2026, Equity Average fell 20.57% year-over-year to $913.7 million; the TTM figure through Mar 2026 stood at $913.7 million (down 20.57% YoY), while the FY2025 annual figure was $1.0 billion, down 5.77% from the prior year.
• Equity Average was $913.7 million for Q1 2026 at Chemed, down from $1.0 billion in the prior quarter.
• In the past five years, Equity Average ranged from a high of $1.2 billion in Q3 2024 to a low of $645.0 million in Q1 2022.
• Historically, Equity Average has averaged $985.2 million across 5 years, with a median of $1.0 billion in 2025.
• The sharpest annual moves came in 2022 and 2023: Equity Average decreased 29.51% in 2022, then jumped 40.17% in 2023.
• A 5-year view of Equity Average shows it stood at $760.1 million in 2022, then jumped by 39.93% to $1.1 billion in 2023, then climbed by 10.7% to $1.2 billion in 2024, then dropped by 12.68% to $1.0 billion in 2025, then retreated by 11.12% to $913.7 million in 2026.
• The last three Equity Average figures came in at $913.7 million (Q1 2026), $1.0 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.